Arsenic Induced Miotic Arrest Associated Apoptosis

砷诱导的缩瞳抑制相关的细胞凋亡

基本信息

  • 批准号:
    7852204
  • 负责人:
  • 金额:
    $ 0.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2009-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Arsenic is a natural contaminant of drinking water in many parts of the world, is a known human carcinogen and is #1 on the EPA list of hazardous chemicals. Cancers most often associated with chronic arsenism are squamous and basal cell carcinomas of the skin. How arsenic causes cancer is unknown. However, the National Research Council Report on Arsenic in Drinking Water concluded that the most likely mode of action is induction of numerical and structural chromosomal abnormalities. Arsenite, the carcinogenic form of arsenic found in drinking water, disrupts mitosis causing an anaphase delay and induces aneuploidy in normal diploid human fibroblasts and peripheral blood lymphocytes, and mitotic arrest associated apoptosis (MAAA) in p53 deficient human fibroblasts. The sensitivity of p53 deficient human cells to arsenite induced MAAA suggests that the mechanism of arsenite carcinogenesis is different than sunlight induced skin carcinogenesis in which p53 mutation is an early and common event. The hypothesis to be investigated is that p53 relieves the arsenite-induced anaphase block by activation of the G2 checkpoint response which inactivates cyclin B/cdc2 and derepresses the mitotic exit network and allow the cells to escape arsenite induced MAAA. It is the prevention of apoptosis in arsenic intoxicated cells that allows genetic instability (aneuploidy) after mitotic disruption. Identification of the cellular factors that interact with p53 or the p53 regulated genes to prevent mitotic arrest associated apoptosis and to allow cells to proceed through mitosis with a delay will provide valuable information regarding the mode of action of arsenite. The specific aims proposed are: 1.) Determine activation of the G2 checkpoint pathway in p53(+) and p53(-) cells arrested by arsenite in mitosis; 2.) Test by overexpression and targeted knockdown of G2 checkpoint proteins the role of G2 checkpoint activation in the escape from arsenite induced anaphase block; 3.) Test whether arsenic associated skin tumors are p53 wild type or mutant. The results of these studies will identify players mediating release from arsenite induced mitotic arrest, and will provide valuable information on the mechanism of arsenic induced carcinogenesis, clues to the usefulness of arsenite as a chemotherapeutic agent and valuable information on the mode of action of mitosis disrupting drugs in killing human cells.
描述(由申请人提供):砷是世界许多地方饮用水的天然污染物,是已知的人类致癌物质,在EPA危险化学品清单上排名第一。最常与慢性砷中毒有关的癌症是皮肤鳞状细胞癌和基底细胞癌。砷如何导致癌症尚不清楚。然而,国家研究理事会关于饮用水中砷的报告得出结论,最可能的作用方式是诱导染色体数量和结构异常。亚砷酸盐是在饮用水中发现的砷的致癌形式,它破坏有丝分裂,导致后期延迟,并在正常二倍体人成纤维细胞和外周血淋巴细胞中诱导非整倍体,以及在p53缺陷的人成纤维细胞中诱导有丝分裂阻滞相关凋亡(MAAA)。p53缺陷的人细胞对砷诱导的MAAA的敏感性表明,砷致癌的机制不同于阳光诱导的皮肤致癌,其中p53突变是早期和常见的事件。待研究的假设是,p53通过激活G2检查点反应来缓解亚砷酸盐诱导的后期阻滞,所述G2检查点反应使细胞周期蛋白B/cdc 2失活并解除有丝分裂出口网络的抑制,并允许细胞逃避亚砷酸盐诱导的MAAA。砷中毒细胞中的细胞凋亡的预防使得有丝分裂破坏后的遗传不稳定性(非整倍体)。鉴定与p53或p53调节基因相互作用以防止有丝分裂阻滞相关凋亡并允许细胞延迟通过有丝分裂的细胞因子将提供关于亚砷酸盐作用模式的有价值的信息。建议的具体目标是:(1)。确定在有丝分裂中被亚砷酸盐阻滞的p53(+)和p53(-)细胞中G2检查点通路的激活; 2.)通过G2检查点蛋白的过表达和靶向敲低来测试G2检查点激活在逃离亚砷酸盐诱导的后期阻滞中的作用; 3.)检测砷相关皮肤肿瘤是否为p53野生型或突变型。这些研究的结果将确定球员介导释放亚砷酸诱导有丝分裂停滞,并将提供有价值的信息砷诱导的致癌作用的机制,线索亚砷酸盐作为化疗剂的有用性和有价值的信息有丝分裂破坏药物杀死人类细胞的作用模式。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evaluation of the serum catalase and myeloperoxidase activities in chronic arsenic-exposed individuals and concomitant cytogenetic damage.
  • DOI:
    10.1016/j.taap.2010.08.013
  • 发表时间:
    2010-11-15
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Banerjee M;Banerjee N;Ghosh P;Das JK;Basu S;Sarkar AK;States JC;Giri AK
  • 通讯作者:
    Giri AK
Suppression of p53 and p21CIP1/WAF1 reduces arsenite-induced aneuploidy.
  • DOI:
    10.1021/tx900353v
  • 发表时间:
    2010-02-15
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Maria Salazar, Ana;Miller, Heather L.;McNeely, Samuel C.;Sordo, Monserrat;Ostrosky-Wegman, Patricia;States, J. Christopher
  • 通讯作者:
    States, J. Christopher
Disruption of Mitotic Progression by Arsenic.
Precancerous and non-cancer disease endpoints of chronic arsenic exposure: the level of chromosomal damage and XRCC3 T241M polymorphism.
Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.
  • DOI:
    10.1186/1757-2215-2-2
  • 发表时间:
    2009-01-14
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Helm CW;States JC
  • 通讯作者:
    States JC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J CHRISTOPHER STATES其他文献

J CHRISTOPHER STATES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J CHRISTOPHER STATES', 18)}}的其他基金

University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10386901
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10600111
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10560120
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
Alternative splicing in arsenical skin carcinogenesis
砷皮肤癌发生中的选择性剪接
  • 批准号:
    9979035
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    9917940
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10600112
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10217134
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10217135
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10817400
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10386902
  • 财政年份:
    2020
  • 资助金额:
    $ 0.98万
  • 项目类别:

相似海外基金

Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
  • 批准号:
    10887038
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
  • 批准号:
    10877239
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
  • 批准号:
    MR/X007979/1
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Research Grant
Cell competition, aneuploidy, and aging
细胞竞争、非整倍性和衰老
  • 批准号:
    10648670
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
  • 批准号:
    10735074
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
  • 批准号:
    10538074
  • 财政年份:
    2022
  • 资助金额:
    $ 0.98万
  • 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
  • 批准号:
    10537275
  • 财政年份:
    2022
  • 资助金额:
    $ 0.98万
  • 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
  • 批准号:
    10661533
  • 财政年份:
    2022
  • 资助金额:
    $ 0.98万
  • 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
  • 批准号:
    10467260
  • 财政年份:
    2022
  • 资助金额:
    $ 0.98万
  • 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
  • 批准号:
    10366610
  • 财政年份:
    2022
  • 资助金额:
    $ 0.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了